Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets

Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets

Unlike traditional cancer therapies, such as surgery, radiation and chemotherapy that are typically non-specific, cancer immunotherapy harnesses the high specificity of a patient’s own immune system to selectively kill cancer cells. The immune system is the body’s main cancer surveillance system, bu...

Full description

Bibliographic Details
Main Authors: Emilie Alard, Aura-Bianca Butnariu, Marta Grillo, Charlotte Kirkham, Dmitry Aleksandrovich Zinovkin, Louise Newnham, Jenna Macciochi, Md Zahidul Islam Pranjol
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
CAR-T cell
checkpoint inhibitor
dendritic cell vaccines
oncolytic viruses
tumour-induced immune evasion
immunosuppression
Online Access:https://www.mdpi.com/2072-6694/12/7/1826

Internet

https://www.mdpi.com/2072-6694/12/7/1826

Similar Items